Nephros, Inc. (NEPH)
3.76
-0.28
(-6.93%)
USD |
NASDAQ |
Feb 12, 16:00
3.75
-0.01
(-0.27%)
Pre-Market: 20:00
Nephros Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Apyx Medical Corp. | -0.519M |
| Owlet, Inc. | -0.255M |
| Abbott Laboratories | -- |
| Accuray, Inc. | -- |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.099M |
| Cash from Financing (Quarterly) | -0.002M |
| Free Cash Flow | 2.719M |
| Free Cash Flow Per Share (Quarterly) | 0.009 |
| Free Cash Flow to Equity (Quarterly) | 0.186M |
| Free Cash Flow to Firm (Quarterly) | 0.099M |
| Free Cash Flow Yield | 6.72% |